What is Bunnell?
Bunnell Inc. is dedicated to advancing respiratory care through its innovative high-frequency jet ventilators. Their flagship products, the LifePulse 203 and 204 models, are engineered to deliver superior physiologic impacts and therapeutic flexibility, establishing a benchmark for gentle infant ventilation. The company's focus extends beyond product delivery to encompass a strong commitment to clinical research, education, and comprehensive customer support for healthcare professionals in neonatal and pediatric intensive care units. Bunnell serves medical institutions requiring effective and user-friendly ventilation options for critically ill infants.
How much funding has Bunnell raised?
Bunnell has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Bunnell
PPP
Public-Private Partnership
What's next for Bunnell?
With the recent major strategic investment, Bunnell is poised for significant expansion. This late-stage funding context suggests a focus on market penetration, potential new product launches, and enhancing manufacturing capabilities to meet growing demand. The company's strategic financing will likely enable further research and development into next-generation ventilation technologies, solidifying its leadership in the neonatal respiratory support sector. Continued investment in clinical validation and global market reach can be anticipated as Bunnell leverages this capital to accelerate its mission of improving patient outcomes.
See full Bunnell company page
